These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 1833896)

  • 1. [Hemodynamic effects of enoximone--comparative studies of heart surgery patients].
    Boldt J; Hempelmann G
    Z Kardiol; 1991; 80 Suppl 4():41-6. PubMed ID: 1833896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Enoximone, a new phosphodiesterase inhibitor: the spectrum of applications during heart surgery--a comparison with dobutamine].
    Boldt J; Kling D; Schuhmann E; Scheld HH; Hempelmann G
    Herz; 1988 Oct; 13(5):335-42. PubMed ID: 2972597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of the hemodynamic effect of enoximone and dopamine in patients after coronary bypass operation].
    Birnbaum DE; Preuner JG; Gieseke R; Kasper-König W; Trenk D; Jähnchen E; Dieterich HA
    Z Kardiol; 1991; 80 Suppl 4():47-52. PubMed ID: 1833897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of enoximone and catecholamines on renal function after open heart surgery].
    Zeplin HE
    Z Kardiol; 1991; 80 Suppl 4():59-62. PubMed ID: 1833899
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparison of new cardiac agents using differential therapeutic criteria].
    Redmann K; Lunkenheimer PP; Rettig G; Isringhaus H; Flameng W; Demeyere R
    Z Kardiol; 1991; 80 Suppl 4():7-14. PubMed ID: 1833902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vasodilatation and positive inotropic effect of the phosphodiesterase inhibitor enoximone].
    Holubarsch C; Hasenfuss G; Thierfelder L; Heiss HW; Just H
    Z Kardiol; 1991; 80 Suppl 4():35-40. PubMed ID: 1833895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].
    Günnicker M; Brinkmann M; Freund U; Piotrowski J; Schieffer M; Velser U
    Herz; 1995 Dec; 20(6):399-411. PubMed ID: 8582699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of a new inotropic agent, enoximone, in heart surgery].
    Gomar C; Fita G; Pomar JL; Valero R; Mulet J; Nalda MA
    Rev Esp Anestesiol Reanim; 1991; 38(2):121-6. PubMed ID: 1678896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Enoximone in postoperative "low-output syndrome"--comparison with dobutamine].
    Orellano L; Darwisch M; Dieterich HA; Köllner V
    Z Kardiol; 1991; 80 Suppl 4():53-7. PubMed ID: 1833898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemodynamic effects of the new phosphodiesterase inhibitor enoximone in heart surgery patients].
    Boldt J; Kling D; Schuhmann E; Dapper F; Hempelmann G
    Anaesthesist; 1989 May; 38(5):238-44. PubMed ID: 2525351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of the enoximone-dobutamine combination in the treatment of congestive cardiac insufficiency].
    Richard C; Thuillez C; Annane D; Bellissant E; Teboul JL
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():33-7. PubMed ID: 2147832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The hemodynamic profile of amrinone and enoximone in patients with severe heart failure].
    Saborowski F; Peters P; Schneider M
    Z Kardiol; 1991; 80 Suppl 4():63-7. PubMed ID: 1833900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of phosphodiesterase inhibitors in anesthesia and intensive care].
    Boldt J; Hammermann H; Hempelmann G
    Z Kardiol; 1994; 83 Suppl 2():75-82. PubMed ID: 8091829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between the positive inotropic effects of enoximone, a cardiac phosphodiesterase III inhibitor, and dobutamine in patients with moderate to severe congestive heart failure. A study using the end-systolic pressure-volume relationship method.
    Installe E; De Coster P; Gonzalez M; Brichant C; Lessire H; Cauwe F
    Eur Heart J; 1991 Sep; 12(9):985-93. PubMed ID: 1834466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative assessment of the effects of 'inodilators' on the myocardium in patients without primary cardiac insufficiency after coronary surgery: Part II--Enoximone.
    Redmann K; Lunkenheimer PP; Isringhaus H; Geiger A; Rettig G; Flameng W; Demeyre T; Engel C; Peterschmidt O
    Thorac Cardiovasc Surg; 1991 Jun; 39(3):129-32. PubMed ID: 1831936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enoximone (MDL 17,043), a phosphodiesterase inhibitor, in the treatment of advanced, unstable chronic heart failure.
    Weber KT; Janicki JS; Jain MC
    J Heart Transplant; 1986; 5(2):105-12. PubMed ID: 2956397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Enoximone--clinical experiences in heart surgery].
    Krüger AD; Francke A; Emmrich K
    Anaesthesiol Reanim; 1996; 21(3):60-8. PubMed ID: 8766397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of R80122. The influence of a new phosphodiesterase inhibitor on global and intestinal hemodynamics in coronary surgery patients].
    Lange H; Stephan H; Autschbach R; Lueerssen K; Zielmann S; Sonntag H
    Anaesthesist; 1992 Aug; 41(8):474-80. PubMed ID: 1524159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive inotropic therapy for short-term support and long-term management of patients with congestive heart failure: hemodynamic effects and clinical efficacy of MDL 17,043.
    Uretsky BF; Valdes AM; Reddy PS
    Circulation; 1986 Mar; 73(3 Pt 2):III219-29. PubMed ID: 2935328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Enoximone/dobutamine comparison in chronic congestive cardiac insufficiency with low cardiac output].
    Galinier M; Rochiccioli JP; Edouard P; Fourcade J; Massabuau P; Puel J; Fauvel JM; Bounhoure JP
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():27-32. PubMed ID: 2147831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.